Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COMy 2022 | Insights into the HealthTree foundation

Nathan Sweeney • 17 May 2022
COMy 2022
Multiple Myeloma Rare Diseases Smoldering Myeloma

Nathan Sweeney, PhD, HealthTree, Lehi, UT, shares some insights into the role of HealthTree, an organization which aims to tailor treatment approaches to patients with multiple myeloma. Dr Sweeney explains the process by which HealthTree accurately makes use of patient information to select the best treatment approaches. This interview took place at the 8th World Congress on Controversies in Multiple Myeloma (COMy) 2022, held in Paris, France.

More from Nathan Sweeney

3:57
Updates from a study investigating exposure to pesticides and the risk of developing myeloma
Nathan Sweeney • 17 May 2022
2:16
The impact of high-dose melphalan on myeloma-related mutations & risk level
Nathan Sweeney • 17 May 2022

Related Videos

0:59
Looking forward to COMy 2024: celebrating 10 years
Mohamad Mohty • 17 Apr 2024
0:57
Overcoming barriers to treating older patients with myeloma
Sergio Giralt • 16 Apr 2024
1:01
The potentially curative role of CAR-T therapy in myeloma
Sergio Giralt • 16 Apr 2024
1:45
Expanded approval of cilta-cel in myeloma: the value of bringing CAR-T cells into earlier lines
Monika Engelhardt • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals